Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||
| Net Income | -68,600 | -29,444 |
| Depreciation Amortization | 844 | 1,878 |
| Accounts payable and accrued liabilities | 2,764 | 3,680 |
| Other Working Capital | 2,516 | 1,294 |
| Other Operating Activity | 10,795 | -8,534 |
| Operating Cash Flow | $-51,681 | $-31,126 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -9,101 | -5,597 |
| Purchase Of Investment | -146,967 | -190,509 |
| Sale Of Investment | 128,853 | 43,390 |
| Other Investing Activity | 0 | -18,688 |
| Investing Cash Flow | $-27,215 | $-171,404 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 101 | 1,815 |
| Common Stock Repurchased | -1,907 | -22 |
| Other Financing Activity | 159,349 | 107,724 |
| Financing Cash Flow | $157,543 | $109,517 |
| Beginning Cash Position | 50,851 | 143,864 |
| End Cash Position | 129,498 | 50,851 |
| Net Cash Flow | $78,647 | $-93,013 |
| Free Cash Flow | ||
| Operating Cash Flow | -51,681 | -31,126 |
| Capital Expenditure | -9,101 | -5,597 |
| Free Cash Flow | -60,782 | -36,723 |